Skip to main content
Vrajesh K. Pandya

Vrajesh K. Pandya, DABCC, PhD

Languages spoken: English

Academic Information

Departments Primary - Pathology

Academic Office Information

Vrajesh.Pandya@path.utah.edu

Education History

Postdoctoral Fellowship University of Utah School of Medicine
Postdoctoral Fellow
University of Alberta
Postdoctoral Fellow
Graduate Training University of Alberta
PhD
Maharaja Sayajirao University of Baroda
MSc
Undergraduate Gujarat University
BSc

Selected Publications

Journal Article

  1. Pandya V, Nguyen Sorenson AHT, Jones E, Young BA, Pearson LN (2022). Spirited away: Can ethanol testing in add-on orders provide meaningful results? Clin Biochem, 115, 97-102.
  2. Pandya V, Wilker C, Johnson-Davis KL (2023). Longitudinal trends in meconium drug detection in 46 US states between the years 2015-2020. J Anal Toxicol.
  3. Pandya V, McMillin GA, Young BA (2022). Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confirmatory Testing? J Appl Lab Med, 8(2), 341-346.
  4. Pandya V, Wilker C, McMillin GA (2021). Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters. J Anal Toxicol, 47(1), 96-105.
  5. Githaka JM, Tripathi N, Kirschenman R, Patel N, Pandya V, Kramer DA, Montpetit R, Zhu LF, Sonenberg N, Fahlman RP, Danial NN, Underhill DA, Goping IS (2021). BAD regulates mammary gland morphogenesis by 4E-BP1-mediated control of localized translation in mouse and human models. Nat Commun, 12(1), 2939.
  6. Salla M, Pandya V, Bhullar KS, Kerek E, Wong YF, Losch R, Ou J, Aldawsari FS, Velazquez-Martinez C, Thiesen A, Dyck JRB, Hubbard BP, Baksh S (2020). Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs. Molecules, 25(17).
  7. Pandya V, Githaka JM, Patel N, Veldhoen R, Hugh J, Damaraju S, McMullen T, Mackey J, Goping IS (2020). BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer. Cell Death Dis, 11(6), 448.
  8. Salla M, Aguayo-Ortiz R, Danmaliki GI, Zare A, Said A, Moore J, Pandya V, Manaloor R, Fong S, Blankstein AR, Gibson SB, Garcia LR, Meier P, Bhullar KS, Hubbard BP, Fiteh Y, Vliagoftis H, Goping IS, Brocks D, Hwang P, Velzquez-Martnez CA, Baksh S (2018). Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis. J Pharmacol Exp Ther, 365(2), 354-367.
  9. Pandya V, Glubrecht D, Vos L, Hanson J, Damaraju S, Mackey J, Hugh J, Goping IS (2016). The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer. Oncotarget, 7(22), 33272-85.

Book Chapter

  1. Pandya V, Frank EL (2022). A Simple, Fast, and Reliable LC-MS/MS Method for the Measurement of Homovanillic Acid and Vanillylmandelic Acid in Urine Specimens. In Methods Mol Biol (2546, pp. 175-183). United States.

Commentary

  1. Pandya V (2022). Commentary on Unexpected Fentanyl Detection during a Liver Transplant Evaluation. Clin Chem, 69(3), 226-227.

Case Report

  1. Smith Z, Goyal P, Pandya V, Thakar CV, Gudsoorkar PS (2023). Hyperuricemia in a patient with Waldenström’s Macroglobulinemia: An innocent bystander? Journal of Onco-Nephrology, 7(2), 79-83.
  2. Pandya V, Hunsaker JJH, Laulu SL, Genzen JR, Frank EL, Johnson LM, Rudolf JW (2021). Excessively low cholesterol and triglyceride levels in an apparently healthy patient. Clin Biochem, 96, 78-81.